. Nonetheless, the last decade has been witness to a growing literature suggesting that in fact the adult brain contains stem cell niches along the entire extent of the ventricular system. These niches are capable of widespread neurogenesis and gliogenesis, particularly after injury (Barnabé-Heider et al.,
Introduction
Stem cells are unique in their remarkable capacity to both self-renew and differentiate into the specialized cells of the body, including the brain (Cheng et al., 2005) . In the embryo, multipotent stem cells comprise the neuroepithelial lining of the neural tube. The differentiation of these cells is guided by critical positional cues present at precise times, ultimately resulting in the diverse neuronal and glial phenotypes found in the brain (Temple, 2001) . As the nervous system matures, the number of neural stem cells (NSCs) in the CNS rapidly declines. By adulthood, NSCs are found only in discrete regions of the CNS where they reside in "stem cell niches". Until recently, only two brain niches, the subventricular zone (SVZ) of the anterolateral ventricle and the subgranular zone (SGZ) of the hippocampal dentate gyrus, were thought to be capable of generating new neurons throughout adult life (Alvarez-Buylla and Lim, 2004; Doetsch et al., 1999a Doetsch et al., , 1999b Doetsch, 2003a Doetsch, , 2003b Lie et al., 2004; Ming and Song, 2005) . However, in the last decade, there has been mounting evidence to show widespread neurogenesis and gliogenesis in the adult brain, particularly after injury (Barnabé-Heider et al., 2010; Carlén et al., 2009; Decimo et al., 2012; Lin et al., 2015; Lindvall and Kokaia, 2008; Robins et al., 2013) or other inductive stimuli (Bennett et al., 2009; Cunningham et al., 2012; Decimo et al., 2011; Kokoeva et al., 2007 Kokoeva et al., , 2005 ; Lee et al., 2012a Lee et al., , 2012b Migaud et al., 2010; Pencea et al., 2001b; Sanin et al., 2013; Suh et al., 2007; Sundholm-Peters et al., 2004; Xu et al., 2005; Zhang et al., 2007) . This review will focus on the role of classic and novel niches in brain homeostasis and in their response to injury.
Historical perspective: the classic brain niches of the SVZ and SGZ
For most of the last century, neuroscientists overwhelmingly believed that the adult brain was essentially an inert structure, incapable of the ongoing production of new neurons. This view was supported by the observations of the neuroanatomist, Santiago Ramón y Cajal, who showed that there was little change in the architecture of the brain after birth (Gross, 2008; Ramon y Cajal, 1928) . However, in the early 1960s, with technological advances such as autoradiography, it became possible to detect [ 3 H]-thymidine incorporation into newly synthesized DNA, allowing researchers to identify and track dividing cells in the SVZ (Messier et al., 1958) and SGZ Das, 1965a, 1965b; Altman, 1963 Altman, , 1962 in the adult brain. Moreover, in 1965, Altman and Das showed for the first time that labeled cells from the SVZ migrated through the rostral migratory stream (RMS) to the olfactory bulb (OB) where they developed into neurons, providing solid evidence of adult neurogenesis in the adult brain Das, 1965a, 1965b) . Further supporting this notion, subsequent electron microscopic studies confirmed that (Kaplan and Bell, 1984; Kaplan and Hinds, 1977) .
Despite these intriguing early findings, it took another twenty years and the advent of new histological methods for identifying dividing cells and tracking their fate in the brain before there was widespread acceptance of the principle of adult neurogenesis. However, with the discovery by Nottebohm and colleagues of thymidine-labeled neurons which co-labeled with antibodies to the synthetic thymidine analog 5-bromo-3 0 -deoxyuridine (BrdU) (Gratzner, 1982; Nowakowski et al., 1989) in hippocampal neurons of the adult songbird Nottebohm, 1996, 1994; Burd and Nottebohm, 1985; Goldman and Nottebohm, 1983; Paton and Nottebohm, 1984) , the SGZ was finally and firmly established as a site for adult neurogenesis. Similar findings in other species (Cameron et al., 1993; Kempermann et al., 1997; Kuhn et al., 1997 Kuhn et al., , 1996 Seki and Arai, 1995) including primates (Gould et al., 1999a) and humans (Eriksson et al., 1998) lent further credence to this concept. Likewise, by tracking with immunocytochemistry, the phenotypic fate of BrdU-labeled cells in the SVZ, during their migration in the RMS, and at their final destination in the OB, the SVZ was similarly shown to be a second site of neurogenesis in the adult brain (Corotto et al., 1994 (Corotto et al., , 1993 Doetsch et al., 1999a; Lois and Alvarez-Buylla, 1994; Pencea et al., 2001a) , including in humans (Curtis et al., 2007) . During this same period, studies in tissue culture played a prominent role in defining and characterizing the cellular and molecular attributes of NSCs from the SGZ and SVZ. In particular, the pioneering work of Reynolds and Weiss and Kilpatrick and Bartlett was pivotal, instituting methods to grow and expand SVZ-derived NSCs as "neurospheres" in the presence of mitogens such as epidermal growth factor. Importantly, these studies established the basic requirements for NSC self-renewal and for their differentiation into neurons and glia (Kilpatrick and Bartlett, 1993; Reynolds and Weiss, 1992) . Similarly, protocols were developed to expand and differentiate NSCs from the SGZ of the hippocampus in culture (Gage et al., 1995; Palmer, 1995; Palmer et al., 1997) . Together, these in vitro studies provided an important platform for future investigations aimed at probing the developmental potentialities of NSCs and the mechanisms regulating their proliferation and differentiation.
NSCs and their niche
As other stem cells of the body, NSCs in the brain were found to reside in specialized structures called niches where cell:cell interactions and local microenvironmental cues were shown to be pivotal in regulating the balance between self-renewal and differentiation. The cellular architecture of the SVZ and SGZ niches and their microenvironment (i.e. growth factors, extracellular matrix molecules, local neurotransmitters, etc.) have been the object of intense investigation over the last decade (for reviews, Basak and Taylor, 2009; Conover and Notti, 2008; Kazanis, 2009) . These findings will be briefly highlighted here, focusing on shared features and key distinctions between these two forebrain niches. Although the names of the principle cell types differ in the SVZ and SGZ, many of the functions and inter-relationships are similar in both niches (Fig. 1A-D) . In the SVZ, slow cycling stem cells (B cells) express the astrocytic marker glialfibrillary acidic protein (GFAP) and give rise to rapidly dividing intermediate progenitor cells (C cells) which cease to express GFAP while acquiring distal-less homeobox (Dlx)-2 expression (Alvarez-Buylla and Garcia-Verdugo, 2002) . Arising from these progenitors are neuroblasts (type A cells) that express the PSA-NCAM (polysialylated neural cell adhesion molecule) and neuronal markers such as doublecortin (Dcx) (AlvarezBuylla and Garcia-Verdugo, 2002) . Chains of neuroblasts leave the SVZ, moving along the RMS before terminating in the OB where they differentiate into interneurons of various types (Alvarez-Buylla and Garcia-Verdugo, 2002; Brazel et al., 2005; Doetsch, 2003a; Kriegstein and Alvarez-Buylla, 2009; Merkle et al., 2007; Mignone et al., 2004) . Similarly, in the SGZ, stem cells termed radial astrocytes (type 1 cells) (Bonaguidi et al., 2012; Fuentealba et al., 2012; Kriegstein and Alvarez-Buylla, 2009; Seri et al., 2001) give rise to intermediate progenitors (type 2a and 2b cells) which express neuronal-specific markers such as Ascl-1 (Achaete-scute homolog-1) and Dcx before moving to the dentate granule cell layer where they integrate into hippocampal circuits (Alvarez-Buylla and Lim, 2004; Basak and Taylor, 2009) .
Although both the SVZ and SGZ are comprised of similar stem and progenitor cell types (Ming and Song, 2011; Mosher et al., 2012; Quiñones-Hinojosa et al., 2006; Sanai et al., 2004; Song et al., 2002) , their architecture within the niche differs, reflecting the differences in their proximity to the cerebral ventricles. Thus, the SVZ which is located along the anterolateral ventricle contains multi-ciliated ependymal cells (E cells). In the SVZ, E cells create a pinwheel formation that at first glance appears to wall off B stem cells from cerebrospinal fluid (CSF). In fact, the cilium of the stem cell is able to penetrate the center of the pinwheel to gain access to CSF and critical factors like insulin-like growth factor (IGF)-2, bone morphogenetic proteins (BMPs), Noggin, Wnts, Sonic hedgehog (Shh), retinoic acid and neurotransmitters (Gross et al., 1996; Lehtinen et al., 2011; Lim et al., 2000; Liu et al., 2002; Mothe and Tator, 2005; Sawamoto, 2006; Xu et al., 2005) . Contrastingly, the SGZ has no E cells or direct contact with the ventricle (Fuentealba et al., 2012) , although the hippocampal sulcus could serve as a potential access point to CSF factors.
Another important feature common to both niches is the rich network of blood vessels surrounding and communicating with stem cells in these sites. In the SVZ, a long basal process extends from B stem cells to terminate directly on endothelial cells in the surrounding vascular plexus (Codega et al., 2014; Kazanis, 2009; Kokovay et al., 2012; Lacar et al., 2012 Lacar et al., , 2011 Mirzadeh et al., 2008; Shen et al., 2008; Tavazoie et al., 2008) . Of particular significance, these vessels lack astrocytic end feet and endothelial cell tight junctions found elsewhere in the brain, resulting in a highly permeable blood-brain-barrier (BBB) at the niche site (Shen et al., 2008; Tavazoie et al., 2008) . Thus, NSCs have potential access to both local endothelial cell-derived factors (i.e. VEGF, BDNF, ephrin-B2, BMP, etc.) and systemic factors present in the blood stream, including circulating cytokines, chemokines and growth factors. While regulation of stem cell behavior due to systemic factors has been little studied until now, recent work from our lab indicates that they may in fact be of paramount importance, particularly after injury (Lin et al., 2015) (see discussion of cues below).
Also present in both forebrain niches are microglial cells which have become a focus of great interest in recent years Molina-Holgado and Molina-Holgado, 2010; Russo et al., 2011; Sierra et al., 2010; Whitney et al., 2009) . Although the exact nature of their interaction with stem cells in the niche remains enigmatic, it is now believed that microglia are important in regulating neurogenesis in the healthy and in the injured/diseased brain. Thus far, electron microscopic and two-photon imaging studies indicate that microglia may be involved in regulating the structure and function of dendritic spines (Fortin et al., 2012) , the perisynaptic environment (Platel et al., 2010; Tremblay and Majewska, 2011) and synapse-pruning (Paolicelli and Gross, 2011; Tremblay and Majewska, 2011) , all of which are required as new-borne neurons develop appropriate connections in the adult brain (Ekdahl, 2012) . Interestingly, in most circumstances, microglial activation and the presence of proinflammatory cytokines (IL-1, INF-gamma and TNF-alpha) results in a decline in neurogenesis (Ekdahl, 2012; Pluchino et al., 2008 ). Yet, in some instances, an increase in microglial cell number has been associated with enhanced neurogenesis, as when rodents are reared in an enriched environment (Ziv et al., 2006) .
Finally, the niche is comprised of a complex and dynamic matrix of extracellular matrix (ECM) molecules and soluble molecules which support, orient and instruct stem cells. Stem cells have laminin receptors (i.e. integrins) on their surface that interact with components (members of the laminin family as well as collagen IV, agrin, nidogen, perlecan) of the surrounding basal lamina (Erickson and Couchman, 2000) . This interaction helps anchor and orient stem cells in the niche (Shen et al., 2008) . Other components in the matrix, like heparan sulfate proteoglycans (HSPG), bind mitogens like FGF-2 (Kerever et al., 2007) while growth factors like NGF can bind other laminins present in the niche (Bhang et al., 2009; Sun et al., 2009 ). Together, these mitogens and growth factors further regulate stem cell proliferation and differentiation (Decimo et al., 2012) . Also of importance are a host of soluble factors (ie. NO, Wnts, etc.) (Castelo-Branco et al., 2006; Decimo et al., 2012; Lie et al., 2005) , including local neurotransmitters like GABA (Liu et al., 2005; Platel et al., 2008; Tozuka et al., 2005) , glutamate (Nacher and McEwen, 2006) and dopamine (Kim et al., 2010; Kippin et al., 2005; O'Keeffe et al., 2009) released from astrocytes, neuroblasts and innervating neurons that may act as master regulators of stem cell activities in the niche (Platel et al., 2010) . New ECM/ soluble factors and niche interactions emerge daily, too numerous to be reviewed here. However, this fertile area of investigation is likely to prove extremely important in understanding regulatory mechanisms in the niche in the future.
4.
Rewriting Dogma: evidence for new niches beyond the SVZ and SGZ
In the past several decades, it has become dogma in the field that adult neurogenesis is limited to the two forebrain zones of the SVZ and SGZ. So entrenched is this concept in the literature that it has been difficult to move beyond the SVZ and SGZ, despite a growing arsenal of evidence of more widespread neurogenesis and gliogenesis throughout the neuroaxis (Barnabé-Heider et al., 2010; Carlén et al., 2009; Decimo et al., 2012; Kokaia et al., 1995; Lin et al., 2015; Lindvall and Kokaia, 2008; Robins et al., 2013) .
Several years ago, our laboratory published data consistent with the existence of additional stem cell niches in structures known as circumventricular organs (CVOs) located along the ventricular midline (Bennett et al., 2009) (Fig. 1E, F) . These sites are also known as the "windows on of the brain" because of their ability to directly receive information from the blood supply and produce critical brain responses in homeostatic functions (pH balance, blood pressure, temperature, circadian rhythm, etc.) (Gross and Weindl, 1987; Joly et al., 2007; Li et al., 2013; Moyse et al., 2006; Price et al., 2008; Roth et al., 2004) . We found that CVO cells possess many of the same characteristics of NSCs in classical niches although details of their cellular composition and architecture remain to be characterized. Like the SVZ, adult CVO stem cells reside in a subventricular location, incorporate BrdU and stain for the proliferation marker Ki67 as well as stem cell markers nestin, vimentin and Sox2. Likewise, proliferating CVO stem cells give rise to new neurons and glia in the culture dish, in the adult brain and after transplantation into the SVZ (Bennett et al., 2009 (Bennett et al., , 2010 . Importantly, like other stem cell niches, CVOs possess permeable fenestrated capillaries and a highly deficient BBB allowing them access to important physiological stimuli that could further regulate neurogenesis in the adult brain (Lin et al., 2015) . As evidence of this fact, it was recently shown that metabolic factors arising from a high fat diet substantially enhance neurogenesis in the median eminence of the hypothalamus (Lee et al., 2012a (Lee et al., , 2012b (Lee et al., , 2014 . Whether CVO stem cells, like NSCs in classic niches, decline with age (Brazel and Rao, 2004; CouillardDesprés, 2013; Encinas et al., 2011; Hamilton et al., 2013; Lee et al., 2012a Lee et al., , 2012b Menn et al., 2006; Seib and MartinVillalba, 2014) or increase with stimuli like exercise (Kuhn et al., 1996; Seki and Arai, 1995; Van Praag et al., 1999) remains to be studied.
In addition to CVOs, our most recent studies further revealed the surprising existence of additional novel niches along the walls of the third (3V) ( Fig. 2A) and fourth (4V) (Fig. 2F) ventricles (Lin et al., 2015) . Interestingly, the cells in these sites fell into two distinctive classes. The first class resembles those of the SVZ and CVO niches in that cells are subependymal in location and stain for stem cell markers nestin, GFAP and Sox2. This class of cells is found along the upper wall of the 3V and surrounding the 4V, particularly near the lateral apertures. The second class of cells is found more inferiorly in the 3V wall. These cells are consistent in location (ependymal lining of midlevel 3V) and morphology (ie. cells with long processes projecting away from the ventricle) to those previously termed tanycytes which exhibit proliferative and neurogenic potential (Chiasson et al., 1999; Spassky et al., 2005) . Bridging the two proliferative zones along the 3V wall is a transitional zone comprised of both subependymal and ependymal cells (Lin et al., 2015) . More inferiorly in the 3V lies the ME and hypothalamus which are also capable of neurogenesis (Decimo et al., 2012; Haan et al., 2013; Kokoeva et al., 2007 Kokoeva et al., , 2005 Migaud et al., 2010; Pencea et al., 2001b; Suh et al., 2007) .
With so many novel niches spread throughout the brain, one might reasonably wonder how these sites escaped detection for so long? The answer may derive from the fact that compared to the SVZ, NSCs in the 3V/4V and CVO niches are present in somewhat lower numbers in the quiescent adult brain. And indeed, it was only after injury and the upregulation of dividing NSCs that these niches became overtly apparent (Lin et al., 2015) (See discussion below). Nonetheless, looking back through the literature, findings from a number of early studies were highly suggestive of their existence. In particular, tissue culture studies dating back to 1992 showed that NSCs could be isolated from the adult third and fourth ventricles and propagated as neurospheres (Bauer et al., 2005; Charrier et al., 2006; Chouaf-Lakhdar et al., 2003; Itokazu et al., 2006; Reynolds and Weiss, 1992; Weiss et al., 1996) , consistent with the presence of NSCs in these locations.
In addition to these novel ventricular niche sites, nestinþ neural progenitor cells in the parenchyma of the cerebral cortex, substantia nigra, amygdala, striatum, etc. have been reported to generate neurospheres and to be capable of giving rise to neurons and glia in culture and after injury or growth factor infusion in vivo (Benraiss et al., 2001; Bernier et al., 2002; Chmielnicki et al., 2004; Collin et al., 2005; Emsley et al., 2005; Gould et al., 1999b; Jiang et al., 2001; Kriegstein and Alvarez-Buylla, 2009; Magavi et al., 2000; Mohapel et al., 2005; Park et al., 2006; Pencea et al., 2001a; Ponti et al., 2008; Teramoto et al., 2003; Van Kampen and Robertson, 2005; Zhao et al., 2003) . However, as no niche structure has been demonstrated to house these cells, and since many of the usual niche relationships to ventricles and leaky vessels are absent, their role in adult brain homeostasis and reconstitution remains unclear and a topic for continued exploration. Finally, the meninges of the spinal cord (Decimo et al., 2011; Petricevic et al., 2011) and the choroid plexus (sometimes considered a CVO) (Itokazu et al., 2006) , have also been shown to contain cells that stain for nestin and which are capable of giving rise to new Dcxþ neurons in vitro and in vivo after injury (Decimo et al., 2011) .
Enhanced neurogenesis and gliogenesis in classic and novel niches following injury
In addition to the homeostatic role that NSCs play in the healthy organism, even in early studies, enhanced NSC proliferation and differentiation was widely reported after various types of brain insult, including mechanical injury (Gould and Tanapat, 1997) , ischemic injury (Arvidsson et al., 2001; Iwai et al., 2001; Jin et al., 2001; Kee et al., 2001; Liu et al., 1998; Takagi et al., 1999; Yagita et al., 2001; Zhang et al., 2001) , seizure (Bengzon et al., 1997; Parent et al., 2002 Parent et al., , 1997 , and excitotoxic lesion (Collin et al., 2005; Gould and Tanapat, 1997; Tattersfield et al., 2004) . In these studies, newly minted neurons and glia derived from the SVZ and SGZ were re-directed from their normal pathway to sites of injury, oftentimes in remote locales. Moreover, in many cases, these diverted cells were capable of differentiating into the specific cell types lost after injury (i.e. medium spiny neurons in the striatum after stroke) (Arvidsson et al., 2002) .
The findings of these early studies raised the possibility that adult niches might serve as an endogenous source of cells for brain repair and thus opened the door to a decade of investigation into stem cell responses to injury. The most well studied model of injury used in these studies is the MCAO (middle cerebral artery occlusion) model of focal ischemia. Uniformly, these studies show a marked but transient amplification of proliferating subependemal NSCs in the SVZ and SGZ, capable of migrating towards the injury and differentiating into new neurons (Barkho et al., 2006; Brazel et al., , 2005 Haas et al., 2005; Kokaia and Lindvall, 2003 b r a i n r e s e a r c h 1 6 2 8 ( 2 0 1 5 ) 3 2 7 -3 4 2 cells in the SVZ which are not involved in constituitive neurogenesis in the healthy brain, transform into proliferating radial glial progenitors, further contributing to the reparative response to stroke (Zhang et al., 2007) . In spite of this vigorous stem cell response to injury, the progenitor cell pool arising from subependymal and ependymal stem cells depletes in the SVZ over time after ischemic injury (Brazel and Rao, 2004; Carlén et al., 2009; Levison et al., 2001; Romanko et al., 2004) .
In addition to the classic stem cell niches, our laboratory recently investigated the response of CVOs and other novel ventricular niche sites to stroke. We found a dramatic and enduring rise in the proliferation of NSCs in the CVOs of MCAO rats (Lin et al., 2015) , similar to that which was observed in the CVOs of ischemic patients (Sanin et al., 2013) . Moreover, because of the significant up-amplification of NSCs after stroke, proliferating subependymal NSCs in 3V (Fig. 2B-D) and 4V (Fig. 2G) niches, predominantly on the side of the injury, were additionally detected for the first time (Lin et al., 2015) . Also as widely reported previously (Barnabé-Heider et al., 2010; Carlén et al., 2009; Ekdahl et al., 2009; Lindvall and Kokaia, 2008; Robins et al., 2013) , enhanced proliferation of ependymal tanycytes lining the mid-level 3V was also observed ipsilaterally after stroke (Fig. 2D, E) or other inductive stimuli (Lee et al., 2012a (Lee et al., , 2012b Migaud et al., 2010; Sundholm-Peters et al., 2004; Xu et al., 2005; Zhang et al., 2007) . It is unlikely that stem cells in these novel ventricular locations have migrated there from more classic niche sites since virally-labeled SVZ NSCs do not appear in the 3V or 4V niches after MCAO (Lin et al., 2015) .
Finally, BrdU-labeled CVO and 3V/4V cells, like classic niche stem cells, are capable of differentiation into prospective oligodendrocytes, astrocytes and neurons following stroke (Lin et al., 2015) . Importantly however, a shift towards neurogenesis was observed after ischemic injury (Lin et al., 2015) , even in niches which predominantly give rise to astrocytes and oligodendrocytes in the healthy brain (Bennett et al., 2009 ). This could have significant clinical implications for repair and recovery after stroke.
Thus, there is growing evidence to show that adult stem cells from a variety of niches throughout the entire neuraxis possess the capacity to generate new replacement neurons and glia after stroke. However, their contribution to long-term functional recovery in the brain remains questionable. Most evidence supporting this notion is, at best, circumstantial. Thus, chains of NSCs appear to migrate along blood vessels away from classic and novel niches, in the direction of the lesion (Lin et al., 2015; Pencea et al., 2001b; Sawada et al., 2014) . Also differentiated BrdU or genetically marked stem cell progeny (ie. neurons and glia) are observed at the striatal infarct site, though their niche of origin remains unknown. Additionally, newly generated NeuN-positive neurons present in the damaged striatum differentiate to express appropriate transmitter types (i.e. DARP-32 and calbindin positive) and elicit long processes with synaptic structures, consistent with but not proof of, restored function after stroke (Arvidsson et al., 2002; Parent et al., 2002; Yamashita et al., 2006) . Similarly, in ischemic patients, there is evidence to indicate that de novo neurogenesis occurs in the penumbra surrounding cerebral infarcts, particularly near blood vessels (Jin et al., 2006; Sanin et al., 2013) . Also, proximal to the stroke site, local striatal astrocytes have been implicated in the production of new neuroblasts (Magnusson et al., 2014) . The relative contributions of these cells and those derived from distant stem cell niches remains to be determined. Despite this robust response to injury, only a minor population of newly generated neurons survive and integrate into the existing neural circuits (Arvidsson et al., 2002; Braun and Jessberger, 2014; Kokaia and Lindvall, 2003; Yang and Wernig, 2013; Zhao et al., 2008) . How we might enhance and sustain the reparative response of endogenous stem cells after injury is an important avenue for future investigation.
6.
Triggering neurogenesis in distant niches after injury: systemic and CSF cues How stem cells, particularly those dwelling in far off niches, are signaled to proliferate and differentiate into new neurons and glia after injury remains a mystery. The long distances that cues must travel from a forebrain injury to a 4V niche are indicative of either a systemic or CSF route of communication, both compartments to which stem cells have ready access. Consistent with the former possibility is the rich vasculature of capillaries present in all stem cell niches (Gómez-Gaviro et al., 2012; Jin et al., 2006; Johnson and Gross, 1993; Palmer et al., 2000; Sawada et al., 2014; Shen et al., 2008; Tavazoie et al., 2008) . Because these vessels lack glial end feet and endothelial tight junctions (Johnson and Gross, 1993; Shen et al., 2008; Tavazoie et al., 2008) , as evidenced by the significant leakage of injected sodium fluorescein dye (Lin et al., 2015) , they are prime candidates for the delivery of circulating factors to stem cell niches (Fig. 3) . Moreover, these sites are made more leaky by stroke which further dismantles the integrity and function of the BBB, particularly on the side of the infarct, thus explaining the enhanced NSC proliferation seen in the ipsilateral SVZ, 3V and 4V niches (CVOs which are small midline structures do not show laterality of response) (Abo-Ramadan et al., 2009; Engelhardt and Liebner, 2014; Iadecola, 2013; Lin et al., 2015) .
These findings raise the possibility that injury-induced factors in the circulating blood could leak through the porous BBB at all niche sites in the brain to regulate endogenous neurogenesis after stroke. However, there has been little recognition of this possibility or investigation along these lines. Most studies have focused on local growth factors and cytokines secreted by other niche cells such as proliferating macrophages/microglia or endothelial cells or by infiltrating immune cells (T cells, neutrophils) at the infarct site (Sawada et al., 2014) . Nonetheless, findings from a number of studies support the possibility of long distance cues traveling through the blood or CSF to influence NSC function in remote niches.
First, low oxygen tension in blood, as occurs in ischemia or stroke, is known to have profound effects on stem cell proliferation and differentiation as well as on vascular components of the stem cell niche (Keith and Simon, 2007; Massouh and Saghatelyan, 2010; Panchision, 2009; Vieira et al., 2011; Zhang et al., 2011) . Many of these changes are believed to be mediated by the transcription factor hypoxia-inducible factor (HIF)-1α, a well-characterized mediator of adaptive transcriptional, metabolic and angiogenic responses to hypoxia. In stem cells, HIF-1α appears to work through the notch and Wnt/β-catenin signaling pathways to enhance their proliferation and differentiation (Cunningham et al., 2012; Hu et al., 2014; Li et al., 2014) . Interestingly, many of the known downstream targets of HIF-1α are those soluble factors (i.e. growth factors, chemokines and cytokines) that have also been inextricably associated with stroke-induced neurogenesis in animals and patients (Bartolini et al., 2011; Ben-Hur et al., 2003; Cacci et al., 2008; Ekdahl et al., 2009; Heldmann et al., 2005; Hermann et al., 2014; Jin et al., 2002; Kallmünzer et al., 2014; Kang et al., 2013; Kitagawa et al., 1999; Kokaia et al., 1995; Leker et al., 2009; Li et al., 2013; Offner et al., 2006; Perez-Asensio et al., 2013; Peruzzotti-Jametti et al., 2014; Planas et al., 1998; Schneider et al., 2005; Sepp et al., 2014; Slevin et al., 2000; Sun et al., 2003; Thored et al., 2009; Zhang et al., 2000; Zhao et al., 2007a Zhao et al., , 2007b . In general, studies of these soluble molecules [i.e. FGF2, glial cell-derived neurotrophic factor (GDNF), brain-derived neurotrophic factor (BDNF), vascular endothelial growth factor (VEGF), transforming growth factor (TGF)-α and β, ciliary neuronotrophic factor (CNTF), erythropoietin (EPO), stromal cell derived factor-1 (SCD-1) and granulocyte-colony stimulating factor (G-CSF), stem cell factor (SCF), IL-1β, IL-6, IL-8] have centered on their secretion by cells in the niche, with little regard for their potential systemic effects on NSCs. Theoretically, bloodborne factors such as circulating EPO, which is induced under conditions of hypoxia via HIF-1α, could directly (or through cross talk) up-regulate growth factors and their receptors like VEGF and VEGF-R to produce pleiotrophic effects on stem cell proliferation, neuroprotection, vasculogenesis and BBB function after stroke (Alnaeeli et al., 2012; Doycheva et al., 2013; Hermann et al., 2014; Piao et al., 2012; Slevin et al., 2000; Yang et al., 2010; Zhao et al., 2007b) .
In addition to systemic signals, our studies (Lin et al., 2015) and those of a handful of others (Lehtinen et al., 2011; Türeyen et al., 2005; Yoshikawa et al., 2010; Zappaterra and Lehtinen, 2012) have also shown that inductive cues are readily transported to niches throughout the brain via CSF. Thus, infusion of bFGF or other growth factors directly into the lateral ventricle stimulates stem cell proliferation and differentiation at multiple stem cell niches along the entire ventricular system. Together these activities may contribute to the "spontaneous" functional recovery seen after stroke in animals and patients.
Conclusions
This is indeed an exciting and transitional period for stem cell research as exciting new evidence continues to show that stem cell niches are not limited to forebrain subventricular and subgranular zones as once believed but instead exist at multiple sites along the entire ventricular system, including in midline CVOs and along the 3V and 4V. Moreover, these novel niches, like classic niches, have the ability to respond to physiological and pathological stimuli with de novo neurogenesis and gliogenesis in the adult brain. Despite these promising findings, there is still much to learn about the new brain niche sites, including details of their cellular composition and cytoarchitecture, their relative contribution to homeostasis in the healthy brain and to repair in the injured or aged brain. Thus far, what is known is that changes as routine as modifications in diet and as severe as stroke can induce de novo neurogenesis in the adult brain. Thus, in the latter case, profound and widespread proliferation of stem cells is observed in all niche sites, predominantly on the ischemic side of the brain. Of further clinical significance is the resulting shift in the differentiative fate of stem cells away from glia and toward new neurons after injury. Whether these new neurons migrate to the site of infarction to replace injured neurons and functionally repair neural circuitry remains to be established. Moreover, identifying the physiological and pathological cues capable of inducing endogenous brain stem cells, the means (i.e. CSF, blood) by which these cues communicate with NSC niches and the molecular pathways they stimulate in NSCs to mediate their effects will be key to harnessing and enhancing the reparative potential of endogenous stem cells. Continued work in this area will no doubt open new avenues of inquiry that may ultimately lead to the therapeutic targets of the future.
